MHRA, NHS England make available new prostate cancer treatment
Bayer, darolutamide, NHS England, NICE, Nubeqa, Orion corporation, Project Orbis, Prostate cancer
0 Comment
News
FDA rejects Spectrum’s lung cancer drug poziotinib
Non-small cell lung cancer, Oncology, poziotinib, regulatory, Spectrum Pharmaceuticals
0 Comment
Opdivo backed by NICE for rare gastro-oesophageal cancers
Bristol-Myers Squibb, gastric cancer, HEOR, immuno-oncology, Keytruda, Merck & Co, oesophageal cancer, Oncology, Opdivo
0 Comment
FDA starts speedy review of Takeda’s dengue vaccine
dengue fever, Dengue vaccine, Dengvaxia, Qdenga, Sanofi, TAK-003, Takeda, vaccine
0 Comment
uniQure, CSL claim first okay for haemophilia B gene therapy
CSL, gene therapy, Haematology, haemophilia, haemophilia B, Hemgenix, regulatory approval, uniQure
0 Comment
Provention finally gets FDA nod for type 1 diabetes drug teplizumab
Diabetes, fda, Provention Bio, regulatory approval, Sanofi, teplizumab, type 1 diabetes, Tzield
0 Comment
FDA panel backs Ardelyx CKD drug, despite agency concerns
Ardelyx, chronic kidney disease, fda, hyperphosphatemia, Ibsrela, Xphozah
0 Comment
Teva says medicines access at risk in Northern Ireland
legislation, market access, northern ireland, Teva, trade
0 Comment
